Jill E. Lavigne

Dr. Lavigne developed the Pharm.D. curricula in pharmacoeconomics, managed care, quality improvement, healthcare delivery, and population health. She was founding faculty advisor of the campus-wide Institute for Healthcare Improvement (IHI) and has mentored students and post-docs in research and teaching. Dr. Lavigne's campus leadership roles have included Co-Chair of Accreditation Review, pharmacy school representative to the Committee on Rank and Tenure, Faculty Council, Faculty Assembly, Long Term Planning and Budget, and Chair of the Professional Development Committee and the Strategic Planning Subcommittee on Faculty and Staff Engagement and Retention. Beyond campus, Dr. Lavigne is an Economist on the New York State Medicaid Drug Utilization Review Board, has served on the editorial board of the Journal of the American Pharmacists' Association, and chaired a review panel for the Centers for Medicare and Medicaid Services. Dr. Lavigne holds degrees in health services research (Ph.D.) and master's degrees in public health (MPH) and public policy (MS) from the University of Rochester and a degree in public policy analysis/East Asian studies (Chinese) from Duke University. Dr. Lavigne studied at Nanjing University and Beijing Teacher's College, and she worked in rural Japan and later traveled the Trans-Siberian Rail to Europe.

Publications

Full List of Publications on Google Scholar

• Pigeon Response to Kawada regarding Comparative safety of insomnia medications and deaths by suicide among veterans, Sleep Medicine. In press. Co-authored with K. Hur and J.B. Gibbons.
• Pigeon Associations between insomnia medications and risk of death by suicide, Sleep Med, Nov. 2023, 199-206. Co-authored with K. Hur and J.B. Gibbons.
• Rural community pharmacists’ perspectives on lethal means management, Clinical Gerontologist, Aug. 2023, 1-13. Co-authored with J. West and D. Carpenter.
• Folic Acid Prescription and Suicide Attempt Prevention: Effect of Past Suicidal Behavior, Psychiatric Diagnosis and Psychotropic Medication, BMJ Psychiatry Open, Aug. 2023. Co-authored with J.J. Mann, K. Hur, R. D. Gibbons.
• Impact of a brief suicide prevention training with an interactive video case, American Journal of Pharmaceutical Education, July 2023. Co-authored with D.M. Carpenter, A. Stover, S. Harris, and H. Anksorus. 
• Development of the Pharm-SAVES educational module for gatekeeper suicide prevention training for community pharmacy staff, Health Expectations, June 2023. Co-authored with A.N. Stover and D. Carpenter.
• The association between vitamin D serum levels, supplementation, and suicide attempts and intentional self-harm in veterans, PLoS ONE 2023. Co-authored with J.B. Gibbons.
• Benztropine and suicide attempts and intentional self-harm, Psychiatry Research, 2023. Co-authored with R.D. Gibbons, K. Hur, and J.J. Mann.
• The Association between Vitamin D Supplementation and Infection with COVID-19 in veterans, Sci Rep, 2022. Co-authored with J.B. Gibbons, E.C. Norton, J.S. McCullough, D.O. Meltzer, V. Fiedler, and R.D. Gibbons.
• Association Between Folic Acid Prescription Fills and Suicide Attempts and Intentional Self-harm Among Privately Insured US Adults, JAMA Psychiatry, Nov. 2022. Co-authored with R.D. Gibbons, K. Hur, and J.J. Mann.
• A scoping review of suicide prevention training programs for pharmacists and student pharmacists, Am J Pharm Educ, Jan. 2022. Co-authored with A.N. Stover and D.M. Carpenter.
• Developing and evaluating a module to teach suicide prevention communication skills to student pharmacists, Currents in Pharmacy Teaching and Learning, Volume 14, Issue 4, 449-456.Co-authored with N. Pothireddy N, A.S. Groman, and D.M. Carpenter.
• Teaching Implicit Bias and Its Management in the Pain Care of Sickle Cell Anemia Patients in a Hyflex Pre-Professional Classroom During COVID-19, Pain Med, March 2022. Co-authored with A. Groman and M. Price.